Suppression of tumorigenicity 18 (ST18) and the homologues neural zinc-finger protein-3 (NZF3) and myelin transcription factor 3 (Myt3) are transcription factors with unknown function. Previous studies have established that they repress transcription of a synthetic reporter construct consisting of the consensus sequence AAAGTTT linked to the thymidine kinase promoter. In addition, ST18 exhibits significantly reduced expression in breast cancer and breast cancer cell lines. We report here for the first time evidence that ST18 mediates tumor necrosis factor (TNF) -␣ induced mRNA levels of proapoptotic and proinflammatory genes in fibroblasts by mRNA profiling and silencing with ST18 small interfering RNA (siRNA). Gene set enrichment analysis and mRNA profiling support this conclusion by identifying several apoptotic and inflammatory pathways that are downregulated by ST18 siRNA. In addition, ST18 siRNA reduces TNF-induced fibroblast apoptosis and caspase-3/7 activity. Fibroblasts that overexpress ST18 by transient transfection exhibit significantly increased apoptosis and increased expression of TNF-␣, interleukin (IL) -1␣, and IL-6. In addition, cotransfection of ST18 and a TNF-␣ or IL-1␣ reporter construct demonstrates that ST18 overexpression in fibroblasts significantly enhanced promoter activity of these genes. Taken together, these studies demonstrate that the transcription factor ST18/NZF3 regulates the mRNA levels of proapoptotic and proinflammatory genes in revealing a previously unrecognized function.-Yang, J., Siqueira, M. F., Behl, Y., Alikhani, M., and Graves, D. T. The transcription factor ST18 regulates proapoptotic and proinflammatory gene expression in fibroblasts. FASEB J. 22, 3956 -3967 (2008) 
The pathophysiology of many disease processes can be understood in terms of changes in gene expression. Transcription factors that control inflammation are particularly important in this regard. They include factors such as activating protein 1 (AP-1), cAMP responsive element binding (CREB), and NF-B, which control genes that regulate inflammatory responses and protect the host from microbial infection, initiate processes such as wound healing, and participate in a number of pathological processes (1) (2) (3) . Inappropriate activity of transcription factors has been shown to promote a number of pathologies, including atherosclerosis, cancer, arthritis, and diabetes (4 -7) . In some cases, inhibiting a transcription factor such as NF-B leads to reduced formation of atherosclerotic lesions (6) .
Like inflammation, apoptosis is also influenced by transcription factors that regulate the expression of pro-or antiapoptotic genes. For example, CREB influences apoptosis by enhancing expression of antiapoptotic genes that promote cell survival (8) . NF-B is also antiapoptotic; it promotes expression of antiapoptotic bcl-2 family members such as cellular FLICE-like inhibitory protein (c-FLIP) and inhibitors of apoptosis (c-IAPs) (9, 10) . The expression of antiapoptotic factors can enhance tumor cell survival and diminish the effectiveness of antitumor chemotherapy (11, 12) . Rb and p53 are two well-defined proapoptotic transcription factors (13, 14) . Defects in p53 or Rb family members may contribute to the pathogenesis and progression of different cancers and resistance of malignant cells to chemotherapy (15) . The forkhead family of transcription factors function similarly to the tumor suppressor p53 and Rb in that both promote apoptosis and affect cell cycle progression (16) . One member, forkhead box O1 (FOXO1), has been shown to play an important role in tumor necrosis factor (TNF) -␣-induced apoptosis by global up-regulation of proapoptotic genes that encode many different functional proteins (17) .
To investigate other transcription factors that may mediate TNF-induced proinflammatory and proapoptotic genes, a pilot study was performed using a transcription factor array from Panomics (Fremont, CA, USA). Suppression of tumorigenicity 18 (ST18) was identified as a putative regulator. Human ST18 is 86% homologous with neural zinc-finger protein-3 (NZF3) (18) . ST18/NZF3 is a member of the myelin transcription factor 1 (MyT1) family of transcription factors that contain zinc-finger DNA-binding domains (19) . It has six C 2 HC-type zinc fingers arranged in two main clusters, each of which binds DNA and recognizes a core consensus sequence. In addition to the zinc-finger domain, the carboxyl terminus of ST18 also displays a high degree of homology to MyT1 and NZF1 (18) . ST18 is constitutively expressed in the brain, with little constitutive expression in the heart, liver, kidney, skeletal muscle, pancreas, testis, ovary, or prostate tissue (20) . It is found at low levels in normal breast tissue, but in a majority of primary breast tumors examined and in breast cancer cell lines, ST18 mRNA is significantly downregulated (20) . Moreover, the same report demonstrates that ectopic ST18 expression inhibits xenograft tumor formation and colony formation in soft agar. Interestingly, ST18 is expressed at 50 higher than normal levels in acute myeloid leukemia and has been proposed as one of 7 markers that have diagnostic potential (21) . However, it remains to be demonstrated that ST18 plays a role in myeloid leukemia development or whether the high level of expression is a secondary event. Despite the potential importance of ST18 in regulating biologically important behavior, little is known about its function or its gene targets. We report here that ST18 plays an important role in regulating the mRNA levels of proapoptotic and proinflammatory genes and that its overexpression significantly enhances apoptosis.
MATERIALS AND METHODS

Cell culture
Primary human adult dermal fibroblasts were purchased (Cambrex, East Rutherford, NJ, USA) and maintained in Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum at 37°C. For most assays, fibroblasts were plated in 6-well plates and assayed in serum-free medium with or without recombinant human TNF-␣ (20ng/ml).
Electrophoretic mobility shift assay (EMSA)
Fibroblasts were stimulated with TNF-␣ (20 ng/ml) for the indicated time. Nuclear protein extracts were obtained using a nuclear extraction kit supplemented with a protease and phosphatase inhibitor cocktail (all from Pierce Biotechnology, Rockland, IL, USA). Nuclear protein concentrations were measured using BCA Protein Assay Kit (Pierce Biotechnology). EMSA was performed using a labeled ST18 DNA binding probe GATCCG-GAAAGTTTGCAAAGTTTGA purchased from Panomics. A positive control cell lysate (Panomics) was used in some experiments, and excess unlabeled ST18 or noncompetitive DNA probe was tested for inhibition of DNA binding. Employing the LALIGN and PLALIGN programs, 3 potential ST18 DNA binding sites in the TNF promoter were identified by setting the parameter of variation to be not more than 3 bases. Three individual unlabeled oligonucleotides were constructed: T1, ATGGGTTTCTCCACCAAGGAAGTTTTCCGC (Ϫ225 to Ϫ196 bp), T2, GCATCCTGTCTGGAAGTTAGAAGGAAAC (Ϫ516 to Ϫ489 bp), and T3, AGGGACCCCAGAGTTCCTTGGAAGC-CAA (Ϫ841 to Ϫ813 bp). In these experiments, fibroblasts were first transfected with ST18 expression vector, described below, for 20 h, and nuclear extracts were examined by EMSA with or without 50-fold excess unlabeled T1, T2, or T3 DNA probes. Dose response to T1 was then assayed using 10-, 50-, and 100-fold excess.
Cloning of ST18 and ST18 overexpression
The ST18 clone (5.9 kb) containing the open reading frame in a pCMV6-XL4 vector was purchased from Origenes Technologies Company (Rockville, MD, USA). Sequencing was performed to confirm isolation of ST18. The open reading frame of the ST18 (3.1 kb) was replicated by polymerase chain reaction (PCR) and the PCR product was purified and inserted into a cDNA 3.1 V5/His TOPO expression vector (Invitrogen, Carlsbad, CA, USA). Cloning of ST18 was again confirmed by DNA sequencing. To overexpress ST18, fibroblasts cells were plated at 80% confluence in 6-well plates. ST18 expression vector was mixed with lipofectamine2000 (Invitrogen) and incubated with cells (0.5 g/ml) in serum-free medium for 16 h. Total RNA was then isolated, and mRNA levels of genes of interest were quantified by real-time PCR. To investigate the direct role of ST18 in fibroblast apoptosis, transient transfection was performed, and apoptosis was measured 24 h later using a cell death detection ELISA kit (Roche, Indianapolis, IN, USA) following the manufacture's protocol. In some experiments, ST18 was cotransfected with luciferase promoter constructs to investigate the effect of ST18 on promoter activity. The reporter construct for TNF-␣ contained sequences Ϫ991 to ϩ1 of the human TNF-␣ gene and has been described elsewhere (22) . Luciferase reporter constructs for human interleukin (IL) -1␣ (Ϫ816 to ϩ177) were purchased from Panomics. A plasmid expressing renilla luciferase was used to control for transfection efficiency (Promega, Madison, WI, USA) and cell lysates were assayed for both firefly and renilla luciferase activity using a dual-reporter assay system (Promega).
Silencing of ST18
ST18 was silenced in order to investigate its functional role in TNF-␣-stimulated gene expression and apoptosis. For the latter, human adult dermal fibroblasts were incubated in 25 cm 2 flasks with 19.3 g of small interfering RNA (siRNA) mixed with RNAiFect Reagent (Qiagen, Valencia, CA, USA). Two ST18 siRNAs were used: siRNA-1 (targeted sequence TCCAATAGGATTTAAATAGAA) and siRNA-2 (targeted sequence CTGGTCAAATCCAAGAAA), both of which had similar effects on cells. However, siRNA-2 was slightly more effective and was used in most of the experiments presented. Scrambled siRNA (AATTCTAAGAACGTGTCACGT) was used as a negative control (csiRNA). Cells were incubated with the transfection complexes overnight in serum free media. After that, the cells were incubated in serum free media for an additional 24 h and then stimulated with TNF-␣ (20 ng/ml) for 6 h.
Real-time PCR
Total RNA was isolated using an RNAeasy Mini Kit (Qiagen). cDNA was prepared by reverse transcription (Applied Biosystems, Foster City, CA, USA) and real-time PCR was performed using TaqMan primers and probe sets (Applied Biosystems). Results were normalized to the values obtained for glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Each experiment was performed 3 times, and the results from the 3 experiments were combined.
Apoptosis and caspase-3/7 activity
Cells were stimulated with TNF for ϳ20 h following transfection with siRNA as described above. Apoptosis was measured by ELISA for cytoplasmic histone-associated DNA (Roche). To assess caspase-3/7 activity, cells were transfected with siRNA and stimulated with TNF as described for the apoptosis assay. Cytoplasmic proteins were extracted using a protein isolation kit from Pierce Biotechnology, and protein concentration was determined using the BCA assay (Bio-Rad Laboratories, Hercules, CA, USA). Cytoplasmic proteins were tested for caspase-3/7 activity measured with a Caspase-Glo TM 3/7 kit from Promega. For each experiment triplicate samples were assessed. Each assay was carried out 3 times and the value represents the mean values Ϯ se of the 3 experiments.
RNA profiling
Microarray analysis was performed using GeneChip human genome U133 plus 2.0 arrays (Affymetrix, Santa Clara, CA, USA). Fibroblasts were transfected with ST18 siRNA or csiRNA as described above and incubated with 20 ng/ml TNF-␣ for 6 h. Total RNA was extracted, and the integrity, purity, and quantity of the samples were determined by agarose gel electrophoresis and optical density readings (A 260 /A 280 ), which were within the range of 1.9 -2.1. RNA was subsequently submitted for microarray analysis at the Harvard Medical School-Partners Healthcare System Center for Genetics and Genomics (Cambridge, MA, USA). Three separate arrays were carried out for each group. The values for each gene were normalized using probe logarithmic intensity error estimate (PLIER; Affymetrix). To be considered as modulated by ST18 siRNA, the intensity value threshold was set at a 2.0-fold increase or decrease compared to csiRNA, with a significance level set at P Յ 0.05, determined by Student's t test. The activation of inflammatory and apoptotic pathways was assessed by gene set enrichment analysis as described (23) . Statistical significance between the two groups, csiRNA vs. ST18 siRNA for a given gene set, was established by setting the false discovery rate at 0.25 and P Ͻ 0.05 using the open source software package described in ref. 23 .
Statistical analysis
Each experiment was carried out with replicate samples per group, and each experiment was performed 3 times. Each value represents the mean Ϯ se of 3 independent experiments (nϭ3). Significance was tested by nonparametric analysis at the P Ͻ 0.05 level by the Mann-Whitney test.
RESULTS
ST18 was identified in a transcription factor activation array (Panomics) as strongly activated in fibroblasts stimulated with TNF-␣ (data not shown). To confirm ST18 activation by TNF-␣, EMSA was performed. TNF-␣ stimulated an increase in ST18 DNA binding activity at 1 h compared to unstimulated cells (Fig. 1A, left panel) . Specificity of binding was demonstrated by the competitive inhibition with excess unlabeled probe (Fig. 1A , right panel). EMSA was also carried out to investigate potential binding sites in the TNF promoter for ST18. Three potential sequences in the TNF promoter were identified and termed T1, T2, and T3, as described in Materials and Methods. In these experiments, fibroblasts were first transfected with the ST18 expression vector, and nuclear extracts were incubated with the labeled DNA probe, Human adult dermal fibroblasts were transfected with ST18 expression vector, and nuclear extracts were examined by EMSA as described in A. Top panel: nuclear extract and labeled oligonucleotide were incubated with 50-fold excess unlabeled oligonucleotide T1, T2, or T3, as indicated. T1, T2, and T3 represent different potential ST18 binding sites in the TNF promoter, as described in Materials and Methods. Bottom panel: excess unlabeled T1 oligonucleotide was added as indicated. C) Real-time PCR was used to quantify the silencing effect of ST18 siRNA. Cells were transfected with two different ST18 siRNAs (siRNA1 or siRNA2) or control scrambled siRNA (csiRNA), and 48 h later were stimulated with or without recombinant human TNF-␣ for 6 h. The results were normalized by GAPDH. Each value represents the mRNA level of the experimental group as the fold difference compared to the no treatment group. Data are expressed as means Ϯ se of 3 experiments. *P Ͻ 0.05 vs. csiRNA.
consisting of the consensus sequence and unlabeled competitive DNA T1, T2, and T3, and examined by EMSA (Fig. 1B, top panel) . Only the T1 probe had the ability to compete with the labeled probe, whereas the T2 and T3 showed no effect. T1 also competed with labeled probe in a dose-dependent manner (Fig. 1B, bottom panel) . Real-time PCR was then performed to determine whether TNF-␣ induced ST18 mRNA and whether ST18 could be silenced with siRNA (Fig. 1C) . TNF-␣ stimulated a 4.2-fold increase in ST18 mRNA levels. Cells were transfected with two different ST18 siRNA oligonucleotides (siRNA1 and siRNA2) or csiRNA (Fig. 1C) . In unstimulated cells, siRNA1 and siRNA2 decreased ST18 mRNA 70 and 80%, respectively, both of which were significant (PϽ0.05). In TNF-␣-stimulated cells, siRNA1 and siRNA2 reduced ST18 mRNA levels 60 and 65%, respectively, compared to csiRNA (PϽ0.05). csiRNA had no effect when compared to TNF stimulation alone (PϾ0.05). In several experiments it was shown that csiRNA ϩ TNF had no effect on gene expression compared to TNF alone; in subsequent experiments the effect of ST18 siRNA was compared to csiRNA.
The role of ST18 in mediating TNF-induced mRNA levels was investigated using ST18 siRNA and by overexpression of ST18. TNF-␣-stimulated TNF-␣ mRNA levels were reduced by 54% by ST18 siRNA compared to csiRNA, demonstrating that ST18 plays a role in stimulated TNF-␣ expression (PϽ0.05) ( Fig. 2A) . To examine the effect of ST18 overexpression, ST18 was cloned into a pcDNA 3.1 TOPO expression vector and transiently transfected into fibroblasts. Compared with transfection of vector alone, ST18 up-regulated TNF-␣ mRNA 4.6-fold (PϽ0.05) (Fig. 2B) .
To demonstrate that ST18 stimulated transcription factor activity, ST18 was cotransfected with a TNF-␣ promoter/luciferase reporter construct (Fig. 2C) . In the absence of cotransfection, luciferase values were low. Transfection of ST18 and the reporter construct increased luciferase activity 4.5-fold compared with empty vector and reporter. A positive control, phorbol 12-myristate 13-acetate (PMA) 10 ng/ml, stimulated a similar level of TNF promoter activity compared with transfection of ST18.
The relation between ST18 and gene expression was further investigated by RNAi studies carried out in conjunction with mRNA profiling using Affymetrix microarrays ( Table 1) . ST18 siRNA was considered to up-or down-regulate TNF-induced mRNA levels if the values were increased or decreased by at least 1.7-fold, with a value of P Յ 0.05 compared to cells incubated with TNF ϩ csiRNA. Of the 579 apoptosis-related genes identified by PathwayArchitect software (Stratagene, La Jolla, CA, USA) using the Gene Ontology database (http://www.geneontology.org) ( Table 1 ), 19.34% were significantly down-regulated by silencing of ST18, 7.42% were significantly up-regulated, and 73.24% did not meet the criteria for being modulated by ST18 siRNA. Seventy-nine proapoptotic and 33 antiapoptotic genes were down-regulated by ST18 siRNA, including many with diverse functions such as ligands, receptors, adapter molecules, transcription factors, etc. (Table 1 ). In comparison, 34 proapoptotic and 9 antiapoptotic genes were up-regulated by ST18 siRNA (Table 1) . Apoptotic genes not regulated by ST18 siRNA are found in Supplemental Table 1 . Because the change in individual genes does not necessarily mean that a given pathway is affected, gene set enrichment analysis was performed to establish whether ST18 modulated sets of genes that regulated apoptosis. The threshold was set at a false discovery rate of 0.25 and a value of P Յ 0.01, as recommended by Subramanian et al. (23) . Several proapoptotic pathways had mRNA values reduced by ST18 siRNA, demonstrating that ST18 plays a role in modulating apoptotic gene sets ( Table 2) . These in- Figure 2 . ST18 enhances TNF-␣ mRNA levels and promoter activity. A) Fibroblasts were transfected with ST18 siRNA2 or csiRNA, followed by stimulation with TNF-␣ (20 ng/ml) for 6 h as indicated. TNF-␣ mRNA levels were measured by real-time PCR. B) Fibroblasts were transfected with empty vector or ST18 expression vector for 24 h. TNF-␣ mRNA levels were measured by real time PCR. C) Fibroblasts were unstimulated or transfected with ST18 expression vector, empty vector, TNF-␣ promoter/luciferase reporter construct, or positive control, cells stimulated with PMA (10 ng/ml). Luciferase activity was measured. Data are expressed as means Ϯ se of 3 experiments. *Significantly increased by cotransfection; P Ͻ 0.05. cluded a pathway designated "apoptosis," which had a very low false-discovery rate and consisted of 67 genes. Pathways consistent with death receptor stimulation included caspase, TNF, and Fas pathways. ST18 siRNA also down-regulated several pathways involved in mitochondrial signaling, even though this pathway does not play a prominent role in TNF-induced apoptosis in fibroblasts (24) , such as mitochondrial pathway, the BCL2 family, BRAC2BRAC1, and ceramide pathways. Antiapoptotic pathways that were negatively modulated by ST18 siRNA included Akt and NF-B. No apoptotic pathways were up-regulated by ST18 siRNA. The GSEA analysis is consistent with the results from individual genes that demonstrate that the effect of ST18 on mRNA levels is overwhelmingly proapoptotic.
Because ST18 promoted proapoptotic gene expression in fibroblasts, its role in apoptosis was assessed by examining the effect of ST18 siRNA on TNF-induced apoptosis and by overexpression of ST18. Without TNF-␣ stimulation, there was little apoptosis detected, and ST18 siRNA had no effect on basal apoptosis (Fig. 3A) . TNF-␣ stimulated a large increase in fibroblast apoptosis. TNF-␣-stimulated apoptosis was significantly reduced by ST18 siRNA, 66% by siRNA2 and 51% by siRNA1 compared to csiRNA (PϽ0.05). The effect of ST18 siRNA and control siRNA is consistent with the degree of silencing observed in Fig. 1C . The role of ST18 in TNF-induced apoptosis was further evaluated by measuring caspase-3/7 activity. TNF-␣ induced a 3.5-fold increase in caspase 3/7 activity, which was reduced by 65% with ST18 siRNA2 compared mRNA profiling was carried out in adult human fibroblasts transfected with ST18 siRNA or csiRNA and then stimulated with TNF-␣ for 6 h. Three separate arrays were carried out for csiRNA and ST18 siRNA, and the values were normalized using a probe logarithmic intensity error estimate (PLIER). To be considered as modulated by ST18siRNA, the intensity values were at least 1.7-fold different compared to csiRNA, with P Յ 0.05.
to csiRNA (PϽ0.05). The effect of ST18 overexpression was tested by transiently transfecting fibroblasts with ST18 expression vector and comparing the results to vector alone and to a positive control, cells treated with TNF-␣. Overexpression of ST18 caused fibroblasts to undergo a 3-fold increase in apoptosis compared to empty-vector transfected cells (Fig. 3C) . This increase was similar to the positive control TNF-␣ tested under the same conditions (Fig. 3C) . These results indicate that ST18 functions to promote apoptosis.
The role of ST18 in regulating mRNA levels of inflammatory genes was examined by RNAi using the same approach described for apoptotic genes. Of the 242 inflammation-related genes identified in the Gene Ontology database (Table 3) , 19 .83% were significantly down-regulated by silencing of ST18, 1.65% were significantly up-regulated, and 78.52% were unchanged. The 48 inflammatory genes down-regulated by ST18 siRNA included cytokines and chemokines, their receptors, transcription factors, etc. (Table 3 ). In contrast, only 4 inflammatory genes were up-regulated by ST18 siRNA (Table 3) . Inflammatory genes not affected by ST18 are shown in Supplemental Table 2 . The effect of inflammatory gene expression was explored further by gene set enrichment analysis (Table 4) . A pathway designated "inflammation" consisting of 29 genes and one designated "cytokine" were significantly down-regulated by ST18 siRNA. Several more specific proinflammatory pathways were down-regulated by ST18 siRNA, such as toll, NF-B, TNF, IL-1 receptor signaling, IL-6, IL-17, interferon, iNOS, NO2/IL-12, and prostaglandin synthesis pathways. No inflammatory pathways were up-regulated by ST18 siRNA. Thus, ST18 modulates several inflammatory pathways stimulated by TNF-␣.
Because mRNA profiling indicated that ST18 mediated TNF-induced mRNA levels of proinflammatory genes, the ability of ST18 to modulate IL-1␣ mRNA levels and promoter activity was examined. ST18 siRNA reduced TNF-␣ induced IL-1␣ mRNA levels by 50% compared to csiRNA (PϽ0.05) (Fig. 4A) . When ST18 was overexpressed, mRNA levels of IL-1␣ were increased 6.4-fold compared to cells transfected with vector alone (PϽ0.05) (Fig. 4B) . To establish whether ST18 enhanced IL-1␣ promoter activity, cells were cotransfected with ST18 and an IL-1␣ promoter/luciferase reporter construct (Fig. 4C) . Cotransfection with ST18 enhanced luciferase activity 3.3-fold compared to cotransfection with vector alone. This was similar to the positive control, IL-1␣ promoter activity in cells stimulated with PMA.
Experiments were also performed to investigate the role of ST18 in modulating another inflammatory mediator, IL-6. Silencing ST18 with siRNA reduced TNF-␣-induced IL-6 mRNA levels by 70% (PϽ0.05) (Fig. 5A) . Overexpressed ST18 up-regulated the mRNA levels of IL-6 5.9-fold compared to transfection with vector alone (PϽ0.05) (Fig. 5B) . To examine whether silencing of ST18 also affected IL-6 expression at the protein level, the supernatants were examined for IL-6 Gene set enrichment analysis was performed with the threshold false discovery rate set at 0.25 and P Ͻ 0.05. The genes defined within a given pathway can be found at http://www.broad.mit.edu/gsea. Figure 3 . ST18 promotes apoptosis. A) Fibroblasts were transfected with ST18 siRNA (siRNA1 or siRNA2) or csiRNA, followed by stimulation with TNF-␣ (20 ng/ml) for 24 h as described in Materials and Methods. Cells were lysed and apoptosis was determined by ELISA, measuring the amount of histone-associated cytoplasmic DNA fragments. B) Fibroblasts were transfected with ST18 siRNA2 or csiRNA and stimulated with TNF-␣ as described in A. Cytoplasmic protein was extracted, and cleaved caspase-3/7 activity was measured with a luminescent substrate. C) Fibroblasts were transfected with culture media alone (no treatment), empty vector, ST18 expression vector, or TNF-␣ (20 ng/ml), and apoptosis was measured 24 h later as in A. Data are expressed as means Ϯ se of 3 experiments. *Significantly reduced by ST18 siRNA (A, B) ; significantly increased vs. no treatment (C); P Ͻ 0.05. mRNA profiling was carried out in adult human fibroblasts transfected with ST18 siRNA or csiRNA and then stimulated with TNF-␣ for 6 h. Three separate arrays were carried out for each group, and the values for each gene were normalized using a probe logarithmic intensity error estimate (PLIER). To be considered as modulated by ST18siRNA, the intensity values were at least 1.7-fold different compared to csiRNA, with P Յ 0.05. protein level by ELISA (Fig. 5C ). On TNF-␣ stimulation, IL-6 protein levels were elevated 2.2-fold in comparison with the unstimulated cells. However, knockdown of ST18 with siRNA resulted in a 50% reduction of IL-6 protein compared to csiRNA. This result correlated well with the degree of down-regulation of IL-6 mRNA level by ST18 siRNA.
DISCUSSION
To better understand how TNF affects fibroblasts to modulate inflammatory or apoptotic gene expression, we identified ST18 as a transcription factor that was induced by TNF stimulation. ST18 is expressed at relatively high levels in brain and at lower levels in other tissues under normal conditions. However, its function has not been elucidated. We report here for the first time that ST18 plays an important role in stimulating proapoptotic and proinflammatory gene expression. The proinflammatory effect of ST18 was demonstrated by 3 approaches. By silencing ST18 with siRNA, it was shown that ST18 had a significant effect on the mRNA levels of almost 20% of proinflammatory genes examined. Approximately 16% of the genes identified by PathwayArchitect as being cytokines were down-regulated by ST18 siRNA, whereas 2.3% of this group were up-regulated. TNF-␣ induces a wide variety of proinflammatory cytokines, including IL-1, IL-2, IL-4, IL-6, IL-10, IL-12, IFN-␥, and TGF-␤ that involves NF-B activation (25) . Microarray results showed that many target genes of NF-B are also affected by ST18 siRNA. Thus, the overall effect of ST18 is to enhance the expression of genes that promote inflammation.
Gene set enrichment analysis was carried out to further establish inflammatory and apoptotic gene sets that are regulated by ST18. Several proinflammatory pathways were shown to be down-regulated by ST18 siRNA, including well-known pathways such as toll, NF-B, TNF, IL-6, iNOS, and prostaglandin synthesis. ST18 overexpression significantly increased TNF-␣, IL-1␣, and IL-6 mRNA levels, and their mRNA levels were reduced when ST18 was knocked down by siRNA. Furthermore, by cotransfection with reporter constructs, ST18 overexpression was shown to stimulate TNF-␣ and IL-1␣ reporter activity. ST18 also repressed promoter activity of HOXA5 (data not shown), consistent with a report that cotransfection of ST18 suppresses transcription activity of a synthetic reporter construct that contains the core consensus AAAGTTT upstream of the thymidine kinase promoter (18) .
Results obtained with microarrays were consistent with data obtained using real-time PCR in studies with siRNA or ST18 overexpression. For example, TNF-␣, GSEA analysis was performed as described in Table 2 .
IL-1␣, and IL-6 were down-regulated by ST18 siRNA whether assessed by microarray or real-time PCR. Of the apoptotic genes regulated by ST18, 70% were proapoptotic, suggesting that ST18 causes an overall shift in gene expression that is proapoptotic. This agreed well with enhanced apoptosis when cells were transfected with ST18 and reduced apoptosis when ST18 was silenced with ST18 siRNA in TNF-␣-stimulated cells. The proapoptotic genes down-regulated by ST18 siRNA included ligands, receptors, adapter molecules, several apoptotic genes known to be modulated by p53 (e.g., c-Fos, c-Jun, Bax, LAT32, and MDM2; ref. 26, 27) , and many proinflammatory genes that are indirectly apoptotic. TNF-␣ activates several intracellular pathways to induce cellular responses that include the production of inflammatory mediators and cell death (25, 28, 29) . Fibroblasts participate in the early response to trauma or microbial invasion by the up-regulation of proinflammatory genes, particularly those involved in innate immunity (30) . However, the inflammatory response can also result in the death of fibroblasts. For example, fibroblast cell death in response to bacterial infection under some circumstances is due to the induced expression of TNF (31) . It has been shown that enhanced fibroblast apoptosis during diabetic healing is due in part to greater levels of TNF and that when fibroblast apoptosis is reduced, healing is improved, which may represent a mechanism for impaired wound healing in diabetic patients (32, 33) . Thus, the effect of TNF on fibroblasts is both important in orchestrating a host response and, in pathological situations, potentially deleterious through excessive apoptosis.
ST18 was first isolated from rat brain tissue. It was identified and characterized using the degenerate primers corresponding to two stretches of conserved sequences in MyT1 and NZF1 from the NZF/MyT family. The cDNA sequence predicts a protein of 1032 amino acids with 6 zinc fingers of the C 2 HC type arranged in 2 clusters, similar to MyT1 and NZF1. Similar to other members of this family, ST18 is shown to be expressed primarily in the nervous system. It has also been reported that ST18 mRNA is significantly down-regulated in breast cancer cell lines and in the majority of primary breast tumors (20) . The finding that ST18 is required for TNF-induced apoptosis suggests a mechanism whereby cells that have reduced ST18 expression may be more resistant to apoptosis. Thus, ST18 may function in a fashion similar to Rb and p53, where reduced expression renders certain cell types resistant to killing by immune surveillance or from chemotherapeutic agents. ST18 enhances IL-6 expression. A) Fibroblasts were transfected with ST18 siRNA2 or csiRNA and then incubated with or without TNF-␣ (20 ng/ml) for 6 h. IL-6 mRNA levels were measured by real-time PCR. B) Fibroblasts were transfected with empty vector or ST18 expression vector for 24 h. IL-6 mRNA levels were measured by real-time PCR. C) Fibroblasts were transfected with siRNA as described in A and then stimulated with ⌻⌵F-␣ (20 ng/ml) for 6 h. IL-6 protein levels were measured by ELISA. Data are expressed as means Ϯ se of 3 experiments. *Significantly reduced by ST18 siRNA vs. csiRNA (A, C); significantly higher than empty vector (B); P Ͻ 0.05.
